Literature DB >> 7796398

Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation.

O Bögler1, H J Huang, W K Cavenee.   

Abstract

Primary cortical astrocytes were isolated from normal (+/+), heterozygous (+/-), or homozygous (-/-) p53-knockout mice. The normal astrocytes grew slowly and underwent crisis after limited division, while the homozygously defective cells grew rapidly and without contact inhibition. These -/- cells could not initially form colonies in soft agarose but acquired this capability after 10 passages in FCS or basic fibroblast growth factor but not epidermal growth factor. Almost all -/- astrocytes weakly expressed glial fibrillary acidic protein at passage 10 and were also A2B5+ when cultured in basic fibroblast growth factor. Most heterozygous cells resembled normal ones; however, some survived crisis, grew rapidly, and formed colonies. Outgrowing cells had all lost the wild-type p53 allele. These molecular and cellular events mimic the early stages of human brain tumors, suggest a role for p53 in the earliest stages of disease progression, and provide an experimental system to analyze the effects of other tumor-specific mutations in the disease process.

Entities:  

Mesh:

Year:  1995        PMID: 7796398

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Growing and differentiating characterization of aortic smooth muscle cell line, p53LMAC01 obtained from p53 knock out mice.

Authors:  T Masuda; K Ohmi; H Yamaguchi; K Hasegawa; T Sugiyama; Y Matsuda; M Iino; Y Nonomura
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Authors:  S Marino; M Vooijs; H van Der Gulden; J Jonkers; A Berns
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 4.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

5.  TWIST is expressed in human gliomas and promotes invasion.

Authors:  Maria C Elias; Kathleen R Tozer; John R Silber; Svetlana Mikheeva; Mei Deng; Richard S Morrison; Thomas C Manning; Daniel L Silbergeld; Carlotta A Glackin; Thomas A Reh; Robert C Rostomily
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

Review 6.  Glioblastoma targeted therapy: updated approaches from recent biological insights.

Authors:  M Touat; A Idbaih; M Sanson; K L Ligon
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 7.  Molecular and genetic pathways in gliomas: the future of personalized therapeutics.

Authors:  Ryan Grant; Luis Kolb; Jennifer Moliterno
Journal:  CNS Oncol       Date:  2014-03

Review 8.  Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

Authors:  Shota Tanaka; David N Louis; William T Curry; Tracy T Batchelor; Jorg Dietrich
Journal:  Nat Rev Clin Oncol       Date:  2012-11-27       Impact factor: 66.675

9.  A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis.

Authors:  J H Tchaicha; A K Mobley; M G Hossain; K D Aldape; J H McCarty
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

10.  Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.

Authors:  Josefine Radke; Ginette Bortolussi; Axel Pagenstecher
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.